Bulletin
Investor Alert

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 7, 2022, 4:02 p.m.

/zigman2/quotes/216320743/composite

$

18.40

Change

0.00 0.00%

Volume

Volume 10,725

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Today's close

$ 19.49

$ 18.40

Change

-1.09 -5.59%

Day low

Day high

$18.29

$19.56

Open

52 week low

52 week high

$14.08

$34.16

Open

Jack Anders

Currently, Jack Anders occupies the position of Principal Financial & Accounting Officer at Revolution Medicines, Inc. Mr. Anders is also Vice President for Anders & Sons, Inc.

In his past career Mr. Anders occupied the position of Vice President-Finance of Assertio Therapeutics, Inc.

Jack Anders received an undergraduate degree from the University of California, Los Angeles.

Transactions

Date Shares Transaction Value
09/01/2022 10,000   Award at $0 per share. 0
06/17/2022 406   Disposition at $17.75 per share. 7,207
03/17/2022 159   Disposition at $18.62 per share. 2,961
03/01/2022 11,600   Award at $0 per share. 0
12/17/2021 170   Disposition at $24.41 per share. 4,150
09/17/2021 166   Disposition at $30.02 per share. 4,984
06/17/2021 160   Disposition at $34.12 per share. 5,460
03/04/2021 7,400   Award at $0 per share. 0
10/13/2020 10,000   Disposition at $44 per share. 440,000
10/13/2020 10,000   Derivative/Non-derivative trans. at $2.68 per share. 26,800
10/06/2020 10,000   Disposition at $40 per share. 400,000
10/06/2020 10,000   Derivative/Non-derivative trans. at $2.68 per share. 26,800

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer & General Counsel
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Dr. Sushil Patel
Director
Ms. Luan M. Wilfong
Senior Vice President-Human Resources
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Eric Schmidt
Independent Director
Dr. Flavia Borellini
Independent Director
Dr. Lorence H. Kim
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.